bimagrumab + semaglutide and Trial Shows Significant Weight Loss | Nature Portfolio posted on the topic Bimagrumab preserves lean mass and
Description
It takes around five minutes and asks about your health, medical history, and weight loss goals

The authors discuss the preclinical literature and emerging clinical evidence that support the rationale for investigating the use of glucagon-like peptide-1 receptor agonists to prevent and treat several neurodegenerative diseases of aging, with a focus on Alzheimers disease.

Learn about the cardiovascular benefits of GLP-1 injections beyond weight loss
Always consult a qualified healthcare professional before starting, stopping, or changing any medication

Google GLP
The study was led by first author Dr Sudipta Sen, associate professor, and senior author and Professor Omonele Nwokolo, both from the Department of Anesthesiology, Critical Care and Pain Medicine at McGovern Medical School at UTHealth Houston."Our findings were quite surprising
